National institutes of health national cancer institute

Date range: 1 July 2021 - 30 June 2022

Parent institution:National Institutes of Health (NIH)

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for NIH National Cancer Institute (NCI) published between 1 July 2021 - 30 June 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

The National Institutes of Health (NIH), part of the Department of Health and Human services, is the U.S.’s primary biomedical research agency. Every year, the NIH grants tens of billions of dollars to hundreds of thousands of researchers studying the causes, diagnosis, prevention, and cure of human diseases, the processes of human growth and development, the biological effects of the environment, and the understanding of mental, addictive, and physical disorders. The NIH funds over 25% of all U.S. biomedical research and has contributed to countless breakthroughs and innovations over the last century. Through the Human Genome Project, completed in 2003, the NIH laid the foundation for personalized medicine.

You can read more about the NIH here: http://www.nih.gov/

The NIH is composed of 27 institutes and centers focused on different areas of disease or functions of the body. The largest of these specialized organizations is the National Cancer Institute (NCI), which is dedicated to cancer research, training scientists, and providing the public with up-to-date information about cancer.

You can read more about the NCI here: http://www.cancer.gov/

A new center within the NIH, the National Center for Advancing Translational Sciences (NCATS) was established in the FY2012 federal appropriations bill at the recommendation of the Institute of Medicine. The goal of NCATS is to look at new and innovative approaches to researching and treating disease. Most NCATS projects are done through the Clinical and Translational Science Awards (CTSAs), which support specialized research facilities and training. One ongoing NCATS project is the Discovering New Therapeutic Uses for Existing Therapies initiative, which partners NCATS with pharmaceutical companies to examine alternative uses for drugs.

You can read more about NCATS here: http://www.ncats.nih.gov/

Funding opportunities

The National Institutes of Health fund basic and translational research aimed at the nation’s highest-priority biomedical challenges; NIH grant funding annually ranks among the largest sources of external support for university researchers.

The National Cancer Institute (www.cancer.gov) is the largest entity within NIH (FY14 budget for NCI was more than $4.9 billion).  Most of its budget is used to fund extramural grants and contracts, organized under several categories.  Information about NCI’s priorities for research, funding opportunities, and links to resources for researchers are all available through the NCI website (www.cancer.gov/research and www.cancer.gov/grants-training).

NCI and NIH communications

NCI offices produce a number of blogs that keep researchers informed of program updates, priorities, and opportunities.  Two of particular interest are:

  • “Cancer Currents” located at http://www.cancer.gov/news-events/cancer-currents-blog ; subscribe there to stay in touch with NCI news and research updates
  • “Dialogue on Disparities” produced by the Center to Reduce Cancer Health Disparities (http://www.cancer.gov/about-nci/organization/crchd/blog )

A blog that comes out of the NIH Office of Extramural Research provides a steady stream of highly useful tips and often fascinating reviews of the status of the entire grant proposal, review, and funding enterprise.  Subscribe to “Extramural Nexus” at http://nexus.od.nih.gov/all/

Participating in proposal review and study sections

Becoming a reviewer, and therefore having the opportunity to read and compare proposals from other researchers and scientific teams, is exceptionally valuable for learning how to write competitive proposals for one’s own funding.  NIH has several mechanisms for connecting scientists with appropriate review opportunities, including a special program for early career researchers or those who have not reviewed previously for NIH.  Find this and other reviewing opportunities and connections at this link:

  • http://public.csr.nih.gov/ForReviewers/BecomeAReviewer

Mentoring connections

NIH supports the National Research Mentoring Network or NRMN, aiming to build support and networks that will further diversify the biomedical workforce.  Register to participate at https://nrmnet.net

Is the National Cancer Institute part of the National Institutes of Health?

The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. Our team of approximately 3,500 is part of the National Institutes of Health (NIH), one of 11 agencies that make up the Department of Health and Human Services (HHS).

Is the National Cancer Institute trustworthy?

This website offers free, credible, and comprehensive information about cancer prevention and screening, diagnosis and treatment, research across the cancer spectrum, clinical trials, and news and links to other NCI websites. The information on this site is science-based, authoritative, and up-to-date.

What does the National Cancer Institute do?

The National Cancer Institute conducts and supports research, training, health information distribution, and other programs related to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Who funds the National Cancer Institute?

As a federal agency, NCI receives its funds from Congress. The bulk of our budget supports extramural grants and cooperative agreements to facilitate research conducted at universities, medical schools, hospitals, cancer centers, research laboratories, and private firms in the United States and abroad.